Faculty profile

Theodore Steiner

ResearcherInfectious Diseases/Internal MedicineUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Theodore Steiner

Researcher

Infectious Diseases/Internal Medicine

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
5 publications in the last five years, latest in 2024.
Principal investigator on 7 research grants (7 CIHR), most recently in 2023.
Supervised 2 trainees who won CIHR awards, most recently in 2011.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

638

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Inflammatory Bowel Disease Clostridium Difficile Chimeric Antigen Receptors Regulatory T Cells T Cells Antibodies Tissue Organoids Tr1 Cells

Latest papers

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study.
Scientific reports · 2024
How to present work productivity loss results from clinical trials for patients and caregivers? A mixed methods approach.
Social science & medicine (1982) · 2023
Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective.
Frontiers in medicine · 2022

All 16 publications

Latest funding

Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform
CIHR · 2025 · Co-investigator
$2,015,775
Exploring the potential of type-1 regulatory T cells in resolution and recovery from intestinal inflammation
CIHR · 2023 · Nominated PI
$925,650
Dexamethasone For Preventing Deterioration In Community Acquired Pneumonia (DEFEND-CAP)
CIHR · 2023 · Co-investigator
$1,375,000

All 17 grants and awards

16 publications.

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study.

Gaultier GN, McMillan B, Poloni C, Lo M, Cai B, Zheng JJ, Baer HM, Shulha HP, Simmons K, Márquez AC, Bartlett SR, Cook L, Levings MK, Steiner T, Sekirov I, Zlosnik JEA, Morshed M, Skowronski DM, Krajden M, Jassem AN, Sadarangani M

Scientific reports2024

DOI: 10.1038/s41598-024-59535-0 PMID: 38637558

How to present work productivity loss results from clinical trials for patients and caregivers? A mixed methods approach.

L'Heureux J, McTaggart-Cowan H, Johns G, Chen L, Steiner T, Tocher P, Sun H, Zhang W

Social science & medicine (1982)2023

DOI: 10.1016/j.socscimed.2023.115999 PMID: 37276772

Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective.

Hocking L, Wilcox M, Petrosillo N, Griffin P, Steiner T, Attara G, Doré J, Cabling M, Stockwell S, Romanelli RJ, Marjanovic S

Frontiers in medicine2022

DOI: 10.3389/fmed.2022.1033417 PMID: 36714122

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.

Shapira T, Vimalanathan S, Rens C, Pichler V, Peña-Díaz S, Jordana G, Rees W, Winkler DFH, Sarai I, Steiner T, Jean F, Pelech S, Av-Gay Y

Molecular biomedicine2022

DOI: 10.1186/s43556-022-00111-1 PMID: 36508083

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.

Shapira T, Monreal IA, Dion SP, Buchholz DW, Imbiakha B, Olmstead AD, Jager M, Désilets A, Gao G, Martins M, Vandal T, Thompson CAH, Chin A, Rees WD, Steiner T, Nabi IR, Marsault E, Sahler J, Diel DG, Van de Walle GR, August A, Whittaker GR, Boudreault PL, Leduc R, Aguilar HC, Jean F

Nature2022

DOI: 10.1038/s41586-022-04661-w PMID: 35344983

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.

de Bruyn G, Gordon DL, Steiner T, Tambyah P, Cosgrove C, Martens M, Bassily E, Chan ES, Patel D, Chen J, Torre-Cisneros J, Fernando De Magalhães Francesconi C, Gesser R, Jeanfreau R, Launay O, Laot T, Morfin-Otero R, Oviedo-Orta E, Park YS, Piazza FM, Rehm C, Rivas E, Self S, Gurunathan S

The Lancet. Infectious diseases2021

DOI: 10.1016/s1473-3099(20)30331-5 PMID: 32946836

Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.

Bouquet J, Li T, Gardy JL, Kang X, Stevens S, Stevens J, VanNess M, Snell C, Potts J, Miller RR, Morshed M, McCabe M, Parker S, Uyaguari M, Tang P, Steiner T, Chan WS, De Souza AM, Mattman A, Patrick DM, Chiu CY

PloS one2019

DOI: 10.1371/journal.pone.0212193 PMID: 30897114

Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Boodman C, Chhonker YS, Murry DJ, Mah A, Grant J, Steiner T, Libman M, Nishi C, Charles M

The American journal of tropical medicine and hygiene2018

DOI: 10.4269/ajtmh.18-0487 PMID: 30226142

Associations of tumor necrosis factor-α-308 polymorphism with dengue infection: A systematic review and meta-analysis.

Pabalan N, Chaisri S, Tabunhan S, Tarasuk M, Jarjanazi H, Steiner T

Acta tropica2017Senior author

DOI: 10.1016/j.actatropica.2017.05.007 PMID: 28495402

Metagenomic Investigation of Plasma in Individuals with ME/CFS Highlights the Importance of Technical Controls to Elucidate Contamination and Batch Effects.

Miller RR, Uyaguari-Diaz M, McCabe MN, Montoya V, Gardy JL, Parker S, Steiner T, Hsiao W, Nesbitt MJ, Tang P, Patrick DM, CCD Study Group

PloS one2016

DOI: 10.1371/journal.pone.0165691 PMID: 27806082

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2023

Subject: Prospective PhD student: Inflammatory Bowel Disease Dear Professor Steiner, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study." (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Exploring the potential of type-1 regulatory T cells in resolution and recovery from intestinal inflammation" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Theodore Steiner

Research

Latest papers

Latest funding

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults&#x2009;&#x2265;&#x2009;50&#xa0;years: a prospective, observational cohort study.

How to present work productivity loss results from clinical trials for patients and caregivers? A mixed methods approach.

Improving care for patients with Clostridioides difficile infection: A clinical practice and healthcare systems perspective.

Inhibition of glycogen synthase kinase-3-beta (GSK3&#x3b2;) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.

A&#xfeff; TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.

Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.

Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Associations of tumor necrosis factor-&#x3b1;-308 polymorphism with dengue infection: A systematic review and meta-analysis.

Metagenomic Investigation of Plasma in Individuals with ME/CFS Highlights the Importance of Technical Controls to Elucidate Contamination and Batch Effects.

Frequent collaborators

William Hsiao

Jennifer Gardy

James Potts

Manish Sadarangani

Wei Zhang

Helen Mctaggart-Cowan

Pierre-Luc Boudreault

Jennifer Grant

Inna Sekirov

Paul Moayyedi

Marek Smieja

Mark Crowther

Yingfu Li

Stephen Michael Collins

Padman Jayaratne

Caigan Du

Patrick Tang

Mel Krajden

Richard Leduc

Yossef Av-Gay

Eric Marsault

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study.

Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.

Associations of tumor necrosis factor-α-308 polymorphism with dengue infection: A systematic review and meta-analysis.